FIELD: medicine.
SUBSTANCE: invention relates to field of medicine. Claimed are immunologically active fragments of polypeptide coded by nucleic acid TOM 34, which possess ability to induce cytotoxic T-cells, containing amino acid sequence SEQ ID NO:7, in which second amino acid from N-end is substituted and represents phenylalanine, tyrosine, methionine or tryptophan, and/or where 1 or 2 amino acids are added on N-end and/or C-end, and/or where C-end amino acid is substituted and represents phenylalanine, leucine, isoleucine, tryptophan or methionine.
EFFECT: invention provides novel epitope for efficient immunotherapy of large intestine cancer.
3 cl, 10 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TOM34 GENE RELATED TO COLON CANCER | 2006 |
|
RU2526196C2 |
| NEIL3 PEPTIDES AND VACCINES INCLUDING SAME | 2010 |
|
RU2600888C2 |
| HJURP PEPTIDES AND VACCINES CONTAINING THEM | 2011 |
|
RU2570560C2 |
| CDC45L PEPTIDES AND VACCINES CONTAINING SAME | 2010 |
|
RU2562160C2 |
| NEIL3 PEPTIDES AND VACCINES COMPRISING THEM | 2010 |
|
RU2733985C2 |
| IMP-3 OLIGOPEPTIDES AND VACCINES CONTAINING THEREOF | 2010 |
|
RU2550695C2 |
| EPITOPIC PEPTIDES RAB6KIFL/KIF20A AND VACCINES CONTAINING THEM | 2009 |
|
RU2532105C2 |
| METHODS FOR TREATMENT OF AUTOIMMUNE DISEASE USING ALLOGENIC T-CELLS | 2017 |
|
RU2773831C2 |
| CDCA1 PEPTIDE AND PHARMACEUTICAL DRUG CONTAINING IT | 2008 |
|
RU2486195C2 |
| MYBL2 EPITOPE PEPTIDES AND VACCINES CONTAINING THEM | 2009 |
|
RU2496787C2 |
